Results 221 to 230 of about 16,238 (237)

Novartis’s canakinumab stumbles in cancer, again

Nature Reviews Drug Discovery, 2021
exaly  

Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome

New England Journal of Medicine, 2009
Eric Hachulla, Pierre Quartier
exaly  

Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis

New England Journal of Medicine, 2012
Nicolino Ruperto, Hermine I Brunner, Pierre Quartier   +2 more
exaly  

Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes

New England Journal of Medicine, 2018
fabrizio De Benedetti, Marco Gattorno, Jordi Anton Lopez   +2 more
exaly  

Long-term effectiveness and safety of canakinumab in pediatric familial Mediterranean fever patients

Modern Rheumatology, 2020
Nesrin Gulez, Balahan Makay, Betul Sozeri   +2 more
exaly  

Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody

Clinical Pharmacokinetics, 2012
Stacey Tannenbaum, Hermann Gram
exaly  

Canakinumab for the treatment of adult-onset Still’s disease

Expert Review of Clinical Immunology, 2020
Paolo Sfriso, Sara Bindoli, Andrea Doria
exaly  

The Use of Canakinumab, a Novel IL-1β Long-Acting Inhibitor, in Refractory Adult-Onset Still's Disease

Seminars in Arthritis and Rheumatism, 2012
Petros Efthimiou
exaly  

Canakinumab

Reactions Weekly, 2015
openaire   +2 more sources

Canakinumab

Reactions Weekly, 2023
openaire   +1 more source